LetterLetter
Anticyclic Citrullinated Peptide Antibodies in Patients with Rheumatic Diseases other than Rheumatoid Arthritis: Clinical or Pathogenic Significance?
SARA CATERBI, ONELIA BISTONI, ALESSIA ALUNNO, ELENA BARTOLONI and ROBERTO GERLI
The Journal of Rheumatology June 2015, 42 (6) 1063-1064; DOI: https://doi.org/10.3899/jrheum.141486
SARA CATERBI
Rheumatology Unit, Department of Medicine, University of Perugia, Perugia,
Italy.
PhDONELIA BISTONI
Rheumatology Unit, Department of Medicine, University of Perugia, Perugia,
Italy.
BScALESSIA ALUNNO
Rheumatology Unit, Department of Medicine, University of Perugia, Perugia,
Italy.
MDELENA BARTOLONI
Rheumatology Unit, Department of Medicine, University of Perugia, Perugia,
Italy.
MDROBERTO GERLI
Rheumatology Unit, Department of Medicine, University of Perugia, Perugia,
Italy.
MDIn this issue
The Journal of Rheumatology
Vol. 42, Issue 6
1 Jun 2015
Anticyclic Citrullinated Peptide Antibodies in Patients with Rheumatic Diseases other than Rheumatoid Arthritis: Clinical or Pathogenic Significance?
SARA CATERBI, ONELIA BISTONI, ALESSIA ALUNNO, ELENA BARTOLONI, ROBERTO GERLI
The Journal of Rheumatology Jun 2015, 42 (6) 1063-1064; DOI: 10.3899/jrheum.141486
Anticyclic Citrullinated Peptide Antibodies in Patients with Rheumatic Diseases other than Rheumatoid Arthritis: Clinical or Pathogenic Significance?
SARA CATERBI, ONELIA BISTONI, ALESSIA ALUNNO, ELENA BARTOLONI, ROBERTO GERLI
The Journal of Rheumatology Jun 2015, 42 (6) 1063-1064; DOI: 10.3899/jrheum.141486